These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Predictive factors for patients receiving intravitreal anti-vascular endothelial growth factor for the treatment of diabetic macular edema. Carroll RM; Yu Y; VanderBeek BL Eur J Ophthalmol; 2020 Jan; 30(1):72-80. PubMed ID: 30764665 [TBL] [Abstract][Full Text] [Related]
23. Vitrectomy for diabetic macular edema: a systematic review and meta-analysis. Simunovic MP; Hunyor AP; Ho IV Can J Ophthalmol; 2014 Apr; 49(2):188-95. PubMed ID: 24767227 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes. Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587 [TBL] [Abstract][Full Text] [Related]
25. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy. di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139 [TBL] [Abstract][Full Text] [Related]
26. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis. Simunovic MP; Maberley DA Retina; 2015 Oct; 35(10):1931-42. PubMed ID: 26398553 [TBL] [Abstract][Full Text] [Related]
27. Current approaches to the management of diabetic retinopathy and diabetic macular oedema. Boscia F Drugs; 2010 Nov; 70(16):2171-200. PubMed ID: 20964459 [TBL] [Abstract][Full Text] [Related]
28. Vitrectomy combined with intravitreal triamcinolone acetonide injection and macular laser photocoagulation for nontractional diabetic macular edema. Kim JH; Kang SW; Ha HS; Kim JR Korean J Ophthalmol; 2013 Jun; 27(3):186-93. PubMed ID: 23730111 [TBL] [Abstract][Full Text] [Related]
29. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy. Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066 [TBL] [Abstract][Full Text] [Related]
30. Practical Lessons from Protocol I for the Management of Diabetic Macular Edema. Mukkamala L; Bhagat N; Zarbin MA Dev Ophthalmol; 2017; 60():91-108. PubMed ID: 28427069 [TBL] [Abstract][Full Text] [Related]
31. A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy. Zhao LQ; Zhu H; Zhao PQ; Hu YQ Br J Ophthalmol; 2011 Sep; 95(9):1216-22. PubMed ID: 21278146 [TBL] [Abstract][Full Text] [Related]
32. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
33. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy. Berrocal MH; Acaba LA; Chenworth ML Curr Diab Rep; 2019 Sep; 19(10):106. PubMed ID: 31529405 [TBL] [Abstract][Full Text] [Related]
34. [Combination therapy in patients with concomitant macular edema and proliferative diabetic retinopathy]. Khomyakova EN; Ryabtseva AA; Sergushev SG; Grishina EE Vestn Oftalmol; 2019; 135(6):67-72. PubMed ID: 32015310 [TBL] [Abstract][Full Text] [Related]
35. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710 [TBL] [Abstract][Full Text] [Related]
36. Association of statin use with the risk of developing diabetic retinopathy. Zhang J; McGwin G Arch Ophthalmol; 2007 Aug; 125(8):1096-9. PubMed ID: 17698757 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy. Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940 [No Abstract] [Full Text] [Related]